Study on the usefulness and safety of warmied infusions and local hot fomentations for vascular pain-like symptoms caused by peripheral intravenous administration of oxaliplatin

Study on the usefulness and safety of warmied infusions and local hot fomentations for vascular pain-like symptoms caused by peripheral intravenous administration of oxaliplatin - usefulness and safety of warmied infusions and local hot fomentations for vascular pain-like symptoms by of Oxaliplatin i.v

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010387

Enrollment

Registered

2013-04-01

Start date

2013-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer patient

Interventions

1st time chemotherapy 1. During heating is described in the report 2. If vascular pain happened, then the warming infusion is start. 3. NRS is performed for 5min, 10min, 15min. Subsequent check is

s report is performed from day 1 to day 8. Subsequently 1. Patients select one of the following before the start of infusion. i) Warming infusion is performed from the time of the appearance of

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Colorectal cancer patients treated with oxaliplatin by peripheral intravenous drip 2) Written patient consent was obtained from patients. 3) XELOX,XELOX+BV or SOX,SOX+BV 4) 20-79 years, gender does not matter

Exclusion criteria

Exclusion criteria: 1)Patients with paresthesia or hemiplegia 2)Patient whose conscious level is not clear 3)Patients who are taking Celecoxib Extension for vascular pain of the time of administration, increased lysates, mixed injection of dexamethasone

Design outcomes

Primary

Measure	Time frame
NRS:Numeric Rating Scale	—

Secondary

Measure	Time frame
enquetes	—

Countries

Japan

Contacts

Public ContactRyoko Kato

Yokohama city university hospital Outpatient chemotherapy room

045-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026